NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,070,039 | +0.9% | 10,505 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $1,060,060 | +4.5% | 10,505 | -4.7% | 0.01% | 0.0% |
| Q1 2023 | $1,013,932 | +1.4% | 11,021 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $999,825 | +17.6% | 11,021 | -1.5% | 0.01% | +14.3% |
| Q3 2022 | $850,000 | -10.1% | 11,188 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $946,000 | -4.7% | 11,188 | -1.1% | 0.01% | +16.7% |
| Q1 2022 | $993,000 | -2.7% | 11,313 | -3.1% | 0.01% | 0.0% |
| Q4 2021 | $1,021,000 | +7.2% | 11,676 | +0.3% | 0.01% | 0.0% |
| Q3 2021 | $952,000 | -17.4% | 11,638 | -7.9% | 0.01% | -25.0% |
| Q2 2021 | $1,153,000 | +5.7% | 12,632 | -1.0% | 0.01% | +14.3% |
| Q1 2021 | $1,091,000 | -9.6% | 12,758 | -0.2% | 0.01% | -22.2% |
| Q4 2020 | $1,207,000 | +11.6% | 12,787 | +2.7% | 0.01% | 0.0% |
| Q3 2020 | $1,082,000 | -0.3% | 12,448 | +0.2% | 0.01% | -10.0% |
| Q2 2020 | $1,085,000 | +8.9% | 12,419 | +2.8% | 0.01% | -9.1% |
| Q1 2020 | $996,000 | -7.1% | 12,075 | +6.7% | 0.01% | +37.5% |
| Q4 2019 | $1,072,000 | +9.5% | 11,317 | +0.5% | 0.01% | 0.0% |
| Q3 2019 | $979,000 | -4.9% | 11,266 | 0.0% | 0.01% | -20.0% |
| Q2 2019 | $1,029,000 | +1.8% | 11,266 | +7.1% | 0.01% | 0.0% |
| Q1 2019 | $1,011,000 | +12.0% | 10,516 | -0.1% | 0.01% | 0.0% |
| Q4 2018 | $903,000 | -1.8% | 10,524 | -1.4% | 0.01% | +25.0% |
| Q3 2018 | $920,000 | +47.9% | 10,673 | +29.7% | 0.01% | +33.3% |
| Q2 2018 | $622,000 | -5.5% | 8,228 | +1.1% | 0.01% | 0.0% |
| Q1 2018 | $658,000 | -3.7% | 8,135 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $683,000 | -5.7% | 8,135 | -3.6% | 0.01% | -14.3% |
| Q3 2017 | $724,000 | +62.7% | 8,435 | +58.1% | 0.01% | +40.0% |
| Q2 2017 | $445,000 | +8.0% | 5,335 | -3.7% | 0.01% | +25.0% |
| Q1 2017 | $412,000 | -19.4% | 5,542 | -21.1% | 0.00% | -33.3% |
| Q4 2016 | $511,000 | -21.7% | 7,021 | -15.1% | 0.01% | -25.0% |
| Q3 2016 | $653,000 | -41.7% | 8,271 | -39.1% | 0.01% | -42.9% |
| Q2 2016 | $1,120,000 | +13.0% | 13,573 | -0.7% | 0.01% | 0.0% |
| Q1 2016 | $991,000 | +6.7% | 13,675 | +26.6% | 0.01% | +7.7% |
| Q4 2015 | $929,000 | +2.4% | 10,800 | +9.5% | 0.01% | -7.1% |
| Q3 2015 | $907,000 | -6.5% | 9,865 | 0.0% | 0.01% | +7.7% |
| Q2 2015 | $970,000 | -15.4% | 9,865 | -15.1% | 0.01% | -18.8% |
| Q1 2015 | $1,146,000 | +25.0% | 11,620 | +17.4% | 0.02% | +23.1% |
| Q4 2014 | $917,000 | +9.4% | 9,900 | +11.2% | 0.01% | 0.0% |
| Q3 2014 | $838,000 | +4.0% | 8,900 | 0.0% | 0.01% | +8.3% |
| Q2 2014 | $806,000 | +5.5% | 8,900 | -1.0% | 0.01% | 0.0% |
| Q1 2014 | $764,000 | +5.7% | 8,990 | -0.1% | 0.01% | 0.0% |
| Q4 2013 | $723,000 | +4.8% | 9,000 | 0.0% | 0.01% | -7.7% |
| Q3 2013 | $690,000 | +38.3% | 9,000 | +27.5% | 0.01% | +18.2% |
| Q2 2013 | $499,000 | – | 7,060 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |